Dose-Ranging Efficacy and Safety Study of Topical Rapamycin Cream for Facial Angiofibroma Associated With Tuberous Sclerosis Complex
Clinical trial NCT03826628 · COMPLETED
Trial details
- NCT number
- NCT03826628
- Sponsor
- Dermatology Specialties Limited Partnership
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-28
- Primary completion
- 2022-09-01
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.